4Filed Sep 15, 8:00 PM ET
EGAIN SVP Chandrasekhar Jadcherla Exercises Options, Sells 6,000 Shares
$EGAN · EGAIN CorpResearch Summary
AI-generated summary of this SEC filing
EGAIN SVP Chandrasekhar Jadcherla Exercises Options, Sells 6,000 Shares
What Happened
- Chandrasekhar Rao Jadcherla, Senior Vice President, Products and Services at EGAIN Corp (EGAN), exercised stock options and sold shares on September 15, 2026. He exercised 6,000 option shares at $2.50 (cost $15,000) and sold 6,000 shares in the open market for aggregate reported proceeds of $30,921 (reported average $5.15). The filing also shows a separate derivative conversion of 6,000 shares reported with $0.00 consideration.
Key Details
- Transaction date: September 15, 2026.
- Exercise: 6,000 shares exercised at $2.50 per share (total $15,000).
- Sale: 6,000 shares sold in the open market; reported average price $5.15 per share (range $5.12–$5.21), total proceeds $30,921. Reporting person can provide breakdown of sales by price on request (footnote).
- Additional derivative entry: 6,000 shares reported as disposed with $0.00 consideration (listed as a derivative transaction).
- Shares owned after the transactions: not specified in the excerpt provided.
- Footnotes: Sales were made under a Rule 10b5-1 trading plan adopted June 9, 2026 (F1). The option exercised is part of a grant representing rights to purchase 61,003 shares that became exercisable beginning Sept 19, 2017 and is now fully vested (F3).
- Timeliness: Filed Sep 16, 2026 for transactions on Sep 15, 2026 — timely under Form 4 rules.
Context
- This pattern (exercise followed by same-day sale) is commonly a cashless exercise where the insider converts options to shares and then sells shares to cover costs or take gains. The sale was executed under a pre-established 10b5-1 plan, which is an automated/structured selling arrangement and may reduce the appearance of trading based on inside information.
- The filing is from an officer (SVP); it does not indicate a 10% owner status. As always, insider sales are not necessarily a signal of company prospects—this one appears routine given the 10b5-1 plan and option exercise.